Maximus Interna. (540401)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

When I look at Maximus Interna, I see a trading and distribution business that is growing its top line but failing to convert that into shareholder value. Sales are up 17.72%, which sounds encouraging, but profits have fallen 29.50%. That is a red flag that immediately catches my attention. A business should not grow its revenue while earnings shrink — it suggests pricing power is weak, costs are rising, or the company is buying growth at the expense of margins. The latest quarter shows sales of ₹43 Cr and net profit of just ₹2 Cr, a thin margin that reinforces my concern. The market price of ₹18.32 has doubled from its 52-week low of ₹8.00, yet the book value is only ₹2.78. At a P/B of 6.59 and ROE of just 5.60%, I am paying a huge premium for a very modest return on equity. Graham would say that buying such a business requires exceptional growth prospects to justify the price. The ROCE of 15.59% is better, but for a trading company with no moat and D/E not available, I worry about hidden leverage or working capital risks. The Piotroski F-Score of 4 out of 9 points to weak financial health. The PEG ratio of 0.82 is misleading because it uses past or expected growth, yet profit growth is negative. This is not a compounding machine. At best, this is a turnaround candidate, but I see no margin of safety at this price. I would need to see a clear path to margin expansion and profit growth before considering it. Until then, this belongs on the 'too hard' pile.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer